Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Nutr Sci Vitaminol (Tokyo) ; 59(3): 232-7, 2013.
Article in English | MEDLINE | ID: mdl-23883694

ABSTRACT

Continuous positive energy imbalance leads to obesity, which increases the risk of developing non-alcoholic fatty liver disease. The hepatoprotective effect of ethyl pyruvate has been revealed in several studies. Therefore, we examined the effect of ethyl pyruvate supplementation on liver cell damage, metabolism, membrane fluidity, and oxidative stress markers in rats fed a high-fat diet. After 6-wk feeding of a control or high-fat diet, Wistar rats were divided into 4 groups: control diet, control diet and ethyl pyruvate, high-fat diet, and high-fat diet and ethyl pyruvate. Ethyl pyruvate was administered as a 0.3% solution in drinking water, for the following 6 wk. Ethyl pyruvate intake attenuated the increase in activities of plasma transaminases and liver TNF-α. However, the supplementation was without effect in the lipid profiles, membrane fluidity or oxidative metabolism in liver induced by the high-fat diet. Our data confirm the potency of ethyl pyruvate against cell liver damage. Nevertheless, prolonged intake did not affect the development of a fatty liver.


Subject(s)
Dietary Fats/adverse effects , Dietary Supplements , Fatty Liver , Liver/drug effects , Pyruvates/pharmacology , Transaminases/blood , Tumor Necrosis Factor-alpha/metabolism , Animals , Biomarkers/metabolism , Cell Membrane/drug effects , Fatty Liver/drug therapy , Fatty Liver/etiology , Fatty Liver/metabolism , Fatty Liver/pathology , Lipid Metabolism/drug effects , Liver/metabolism , Liver/pathology , Male , Non-alcoholic Fatty Liver Disease , Obesity/complications , Oxidative Stress/drug effects , Pyruvates/therapeutic use , Rats , Rats, Wistar
2.
Biosci Biotechnol Biochem ; 75(3): 500-4, 2011.
Article in English | MEDLINE | ID: mdl-21389621

ABSTRACT

Although a number of studies have focused on the higher ethyl pyruvate antioxidative activity than its sodium salt under various stress conditions, and the greater protective properties of the ester form have been suggested as the effect of better cell membrane penetration, the molecular mechanism has remained unclear. The aim of the present study was therefore to compare the antioxidative activities of sodium and ethyl pyruvate under in vitro conditions by using a liver homogenate as the model for cell membrane transport deletion. The potential effect of ethanol was also evaluated, and hypochlorous acid was used as an oxidant. Our data indicate the concentration-dependent scavenging potency of both sodium and ethyl pyruvate, with the ester having higher activity. This effect was not related to the presence of ethanol. Better protection of the liver homogenate by ethyl pyruvate was also apparent, despite the fact that cell membrane transport was omitted.


Subject(s)
Cell-Free System/drug effects , Esters/pharmacology , Oxidation-Reduction/drug effects , Pyruvates/pharmacology , Animals , Benzofurans/analysis , Benzothiazoles/analysis , Biological Transport , Cell-Free System/metabolism , Ethanol/metabolism , Hypochlorous Acid/adverse effects , Liver/drug effects , Liver/metabolism , Models, Biological , Oxidative Stress/drug effects , Permeability , Rats , Rats, Wistar , Sodium/metabolism , Sulfonic Acids/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...